About Biotech Accelerationism (BIO/ACC):
The current snapshot places Biotech Accelerationism (BIO/ACC) at $0.0000951, supported by a $95.11K market cap and $57.11K 24h volume. Liquidity remains fast turnover relative to market cap (volume/market cap 60.05%) High turnover can improve execution quality but may come with quicker regime shifts..
Market assessment:
Bull score 30/100 suggests weak momentum with cautious participation with continuation signals that remain fragile..
Return snapshot: 24h -30.00%; 7d 0.00%; 30d 0.00%. Returns are uneven across windows, consistent with mixed short-term structure.
Near-term conditions look more volatile on this snapshot. Risk is assessed as Low, which implies more stable conditions with tighter volatility behavior Liquidity changes can alter the risk profile quickly..
Biotech Accelerationism (BIO/ACC) is positioned in the Late phase,
typically associated with conditions consistent with late-cycle maturity Liquidity can remain high even as structure becomes less stable..
Supply design details are limited in the current snapshot fields.
Conclusion: In summary, current conditions suggest a defensive structure where capital preservation becomes a priority. Update date: 2026-05-02.
YearBull Rank timeline
Current YearBull Rank for biotech-accelerationism: #6542.
Rank timeline (last 365 days)
Rank change (reference points).
Reading rule: lower is better in this ranking.
- 7d window: no reference point available.
- 30d window: no reference point available.
Risk read: the same move can be stable in one market and fragile in another.
Liquidity context: a quiet tape can still re-rank the pack.
Venue angle: improvement with higher churn can be a rotation phase.
Market phase: a quick bounce can still be a mean-reversion phase.
YearBull Rank is a relative ranking on YearBull designed to compare coins on a common scale and time window. Lower values mean higher placement in the YearBull ordering. It is meant for comparison and tracking, not certainty.
Editorial note:
This analysis was prepared by the YearBull research team under the direction of
Alan Zelvin,
Founder and Lead Crypto Researcher.
The assessment follows YearBull’s internal research methodology and editorial standards.
Methodology ·
Editorial Policy
Comments